GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cantourage Group SE (XTER:HIGH) » Definitions » EV-to-Revenue

Cantourage Group SE (XTER:HIGH) EV-to-Revenue : 2.81 (As of May. 25, 2025)


View and export this data going back to 2022. Start your Free Trial

What is Cantourage Group SE EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Cantourage Group SE's enterprise value is €67.05 Mil. Cantourage Group SE's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €23.86 Mil. Therefore, Cantourage Group SE's EV-to-Revenue for today is 2.81.

The historical rank and industry rank for Cantourage Group SE's EV-to-Revenue or its related term are showing as below:

XTER:HIGH' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.81   Med: 3.96   Max: 265.65
Current: 2.81

During the past 5 years, the highest EV-to-Revenue of Cantourage Group SE was 265.65. The lowest was 1.81. And the median was 3.96.

XTER:HIGH's EV-to-Revenue is ranked worse than
55.84% of 976 companies
in the Drug Manufacturers industry
Industry Median: 2.37 vs XTER:HIGH: 2.81

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-25), Cantourage Group SE's stock price is €5.82. Cantourage Group SE's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €1.91. Therefore, Cantourage Group SE's PS Ratio for today is 3.04.


Cantourage Group SE EV-to-Revenue Historical Data

The historical data trend for Cantourage Group SE's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantourage Group SE EV-to-Revenue Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
- - - 280.95 3.75

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-Revenue Get a 7-Day Free Trial - 280.95 - 3.75 -

Competitive Comparison of Cantourage Group SE's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cantourage Group SE's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's EV-to-Revenue falls into.


;
;

Cantourage Group SE EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Cantourage Group SE's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=67.050/23.856
=2.81

Cantourage Group SE's current Enterprise Value is €67.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cantourage Group SE's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was €23.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE  (XTER:HIGH) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Cantourage Group SE's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=5.82/1.914
=3.04

Cantourage Group SE's share price for today is €5.82.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Jun. 2024 was €1.91.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cantourage Group SE EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Cantourage Group SE's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Cantourage Group SE Business Description

Traded in Other Exchanges
N/A
Address
Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is a medical cannabis company. The company offers products in all relevant market segments: dried flowers, extracts, Dronabinol, and pharma-grade Cannabidiol.
Executives
Patrick Hoffmann Supervisory Board
Dr. Florian Kainzinger Supervisory Board
Dr. / Dr. Florian / Michael Kainzinger / Ruoff Supervisory Board
Dr. / Dr. Florian /michael Kainzinger / Ruoff Supervisory Board
Dr. / Herr Florian / Patrick Holzapfel / Hoffmann Supervisory Board
Dr. Florian Holzapfel Supervisory Board
Dr. Michael Ruoff Supervisory Board

Cantourage Group SE Headlines